
"Questioning the Efficacy of a Common Anxiety Pill: A Closer Look"
A re-evaluation of trials and studies on the efficacy of Xanax, a commonly prescribed anxiety medication, has found that its effectiveness may have been exaggerated by approximately 40 percent due to publication bias. While still more effective than a placebo, the drug's efficacy was inflated in published studies. Only one out of the five trials reviewed by the FDA was deemed positive, raising questions about the drug's actual effectiveness. Xanax, a benzodiazepine, is known for its addictive nature and potential side effects. The study highlights the need for further examination of the drug's efficacy and raises concerns about its widespread use.



